J 2021

Sheep as a Potential Model of Intradiscal Infection by the Bacterium Cutibacterium acnes

COSCIA, E.C., N.S. ABUTALEB, B. HOSTETTER, M.N. SELEEM, G.J. BREUR et. al.

Základní údaje

Originální název

Sheep as a Potential Model of Intradiscal Infection by the Bacterium Cutibacterium acnes

Autoři

COSCIA, E.C., N.S. ABUTALEB, B. HOSTETTER, M.N. SELEEM, G.J. BREUR, R.R. MCCAIN, C.J. CRAIN, Ondřej SLABÝ (203 Česká republika, garant, domácí), M.N. CAPOOR, A. MCDOWELL, externista FAHAD AHMED (840 Spojené státy), V. VIJAYANPILLAI, S.K. NARAYANAN a M.F. COSCIA

Vydání

Polish Journal of Veterinary Sciences, Olsztyn, Polish Academy of Sciences Committee of Veterinary Sciences, University of Warmia and Mazury in Olsztyn, 2021, 2306-7381

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

40301 Veterinary science

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.518

Kód RIV

RIV/00216224:14740/21:00124251

Organizační jednotka

Středoevropský technologický institut

UT WoS

000634239500001

Klíčová slova anglicky

Cutibacterium acnes; sheep model; spinal intervertebral discs; percutaneous injections; bacterial discitis

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 18. 5. 2022 13:39, Mgr. Pavla Foltynová, Ph.D.

Anotace

V originále

The anaerobic bacterium Cutibacterium acnes has been increasingly linked to the development of degenerative disc disease (DDD), although causality is yet to be conclusively proven. To better study how this organism could contribute to the aetiology of DDD, improved animal models that are more reflective of human disc anatomy, biology and mechanical properties are required. Against this background, our proof-of concept study aimed to be the first demonstration that C. acnes could be safely administered percutaneously into sheep intervertebral discs (IVDs) for in vivo study. Following our protocol, two sheep were successfully injected with a strain of C. acnes (8.3 x 10(6) CFU/disc) previously recovered from a human degenerative disc. No adverse reactions were noted, and at one-month post inoculation all triplicate infected discs in our first animal grew C. acnes, albeit at a reduced load (5.12 x 10(4) to 6.67 x 10(4) CFU/disc). At six months, no growth was detected in discs from our second animal indicating bacterial clearance. This pilot study has demonstrated the feasibility of safe percutaneous injection of C. acnes into sheep IVDs under fluoroscopic guidance. The design of follow-up sheep studies to investigate the potential of C. acnes to drive pathological changes within infected discs should now be pursued.